Search results

Discover how Medable helped digitize and standardize a client's participant pain body maps for a diabetic polyneuropathy trial.

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

This DBM App is the app and analytics platform for healthcare. Review the Medable DBM app Privacy Statement here.

On December 23, 2023, the FDA released guidance for the industry on how digital health technologies (DHTs) should be used in clinical trials. Below is a summary of each section contained above, to read through the FDA’s full text, click here.

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

Accelerate therapeutic discovery and maximize ROI with our streamlined platform, fully integrated across your entire portfolio. Use digital and decentralized trials to scale your pipeline beyond what's possible with traditional clinical trials.

Join leading clinical experts as they discuss and debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter, faster decisions.

Explore the prevalent challenges encountered in eCOA clinical trials, from technical issues and patient adherence to data security and regulatory adherence, and discover strategies for mitigation.

With MarketsandMarkets projecting the global electronic Clinical Outcome Assessments (eCOA) solutions market to grow at compound annual growth rate (CAGR) of 16.1% each year until 2030, it’s clear the eCOA has made its impact within the clinical research landscape. Yet despite growing adoption, electronic Clinical Outcome Assessments (eCOA) are still surrounded by misconceptions that hinder their full potential. From concerns about patient usability to assumptions about cost and implementation timelines, these myths can create hesitation among sponsors and research teams alike.Thus, we’re here to cut through the noise and set the record straight with a summary of a recent webinar featuring speakers from Transcelerate and Medable.

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

In January 2024, panelists from Syneos, Obvious Ventures, Sapphire Ventures, IDEA Pharma, and GSR Ventures joined Medable’s CEO, Dr. Michelle Longmire, to discuss the purpose, potential, and power that artificial intelligence (AI) technology offers clinical trials. Here's what they had to say.

Within clinical research, email is not just a compliant and valuable tool, it’s commonly the gold standard when communicating with participants. Read on to find out why.

Medable's Site experience helps clinical research sites simplify trial operations, reduce admin burden, and focus on patient care and data quality with one easy-to-use platform.

The TOGETHERCare App was created to help caregivers implement home-based care for cancer survivors. Review the Medable TOGETHERCare app Privacy Statement here.

Medable's Access app was created during the epidemiological emergency created by the SARS-CoV-2 virus. Review the app privacy statement here.

Navigating the complexities of eCOA vendor selection can be tough. This comprehensive guide provides a step-by-step approach, covering everything from vendor evaluation to successful implementation, ensuring your clinical trial's success.

Medable’s AI capabilities are advanced tools designed to enhance clinical trial processes by automating and optimizing the eCOA build experience. These capabilities leverage cutting-edge AI technology to automatically generate the digital version of an eCOA from the paper version (PDF). Medable’s AI empowers users to accomplish repetitive build activities, such as repeated scales for long questionnaires, using simple prompts in our intelligent chat interface.

Gain a quick overview of what top trends and topics dominated DIA 2023.

Explore practical strategies for ensuring data quality in eCOA clinical trials, covering platform design, patient engagement, data validation, and regulatory adherence.

This blog describes software as a service and how the life sciences industry uses it today.

With the 14th annual DPHARM® wrapping up, we talked to our peers across the industry to find out what the big themes and takeaways were from this year’s conference.

Electronic patient-reported outcomes and electronic clinical outcome assessments capture real-time, quality data for clinical trials. Learn how at Medable.

Learn why patient-centric ePRO instrument design is critical to driving study success, provides tips on how to make instruments more patient-centric, and offers resources for additional ePRO design guidance.

Consult directly with an award-winning Medable SME about your trial and discover how to enable faster, easier, clinical trials through patient-focused experiences. Chat about best practices in protocol design and digital standardization, learn how the latest FDA & EU guidelines will impact you, or see client use cases on cost and time savings.

Learn how we can help you navigate the complexities of clinical operations so that you can meet your study's milestones faster and easier.

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

See how customers have had success with Medable, our trial platform, and our teams.

Learn the basics of digital medicine and how it's evolving with this blog.

Streamline your clinical trial and generate high-quality data with a #1 rated, easy-to-use platform, offered in over 60 countries and 120 languages. Book a demo to learn more.

The partnership between Medable, U.S. Renal Care, and the top ten pharmaceutical sponsor exemplifies the transformative power of Medable’s Total Consent solution in clinical trials. By overcoming common misconceptions around participant age, cost, and complexity, Medable’s platform proved to be a flexible, fast, and efficient solution for the elderly renal care population. U.S. Renal Care sought to use Medable’s Total Consent (Medable’s eConsent solution) for an investigator-initiated trial. The phase 4 trial, which was funded by a top 10 pharmaceutical company, sought to enroll elderly participants suffering from Anemia ESKD (End Stage Kidney Disease) across 476 site users. The trial would be managed by three central principal investigators (PIs).

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

Accelerate clinical trials with an agentic AI platform and best-in-class eCOA solutions. Streamline clinical development, eliminate bottlenecks, and achieve better outcomes.

This Televisit App facilitates visits between a healthcare provider & patient in a HIPPA-secure manner. Review the Medable Televisit app Privacy Statement here.

Learn what impacts the new European Medicine Regulatory Network recommendations paper means to your clinical trial operations.

Get the basics on ClinROs, why they are important, the industry governance around them, and how their electronic versions can benefit clinical trials.

See how a pharmaceutical company used data gathered during the informed consent process to pre-populate their site's systems, as well as their own.